Pipeline Hero Background

Differentiated regenerative therapies,
developed at field pace

With our regenerative biology platform and a multidisciplinary team spanning veterinary clinicians, academic researchers, and industry operators, we translate stem cell and exosome science into antibiotic-light therapeutics for animal health. Our pipeline is built around rigorous validation, standardized manufacturing, and real-world usability—so advanced biologics can be trusted, deployable, and scalable in routine care.

Founded in 2021, we're proud of the progress we've made so far. And we're just getting started.

Icon

Several NOX
regenerative programs
are already progressing
through R&D and field
validation.
Watch their progress.

Icon

Potential best-in-class therapies for animal health conditions

Program Animal Indication Discovery Proof of concept Controlled Pivotal study Commercial
NXE-91-M
 Dairy cow Subclinical and clinical mastitis
Pivotal study-ongoing
NXS-75-M
 Dairy cow Subclinical and clinical mastitis
Pivotal study-ongoing
NXE-86-Kid
 Cat Chronic Kidney Disease
PoC-enabling
NXE-121-AD
 Dog Atopic Dermatitis
Discovery
NXC-45
 Calf IgG absorption
Discovery

Healthy life is every animal's right

We're advancing animal health by translating stem cell and exosome science into antibiotic-light, regenerative therapeutics.

We achieve this through close collaboration with veterinary clinicians, academic research groups and research centers, and both local and industrial partners.

Partners Icon
OUR PARTNERS

Be a part of our progress

Together, we can scale healing—multiplying what biology already does best: repair, balance, and resilience.

Partner With Us Join The Team